Article Versions Notes

Wang X, Wang D, Ding N, Mi L, Yu H, Wu M, Feng F, Hu L, Zhang Y, Zhong C, et al. The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma. Cancers. 2021; 13(17):4249. https://doi.org/10.3390/cancers13174249

Wang, Xing, Dedao Wang, Ning Ding, Lan Mi, Hui Yu, Meng Wu, Feier Feng, Luni Hu, Yime Zhang, Chao Zhong, and et al. 2021. "The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma" Cancers 13, no. 17: 4249. https://doi.org/10.3390/cancers13174249

Wang, X., Wang, D., Ding, N., Mi, L., Yu, H., Wu, M., Feng, F., Hu, L., Zhang, Y., Zhong, C., Ye, Y., Li, J., Fang, W., Shi, Y., Deng, L., Ying, Z., Song, Y., & Zhu, J. (2021). The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma. Cancers, 13(17), 4249. https://doi.org/10.3390/cancers13174249